The Preterm Infants' Paracetamol Study
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 120 participants.
Also called NCT01938261
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 2
- Enrolled
- 120 participants
- Sponsor
- University of Oulu
- Registry
-
NCT01938261 -
2013-001842-33
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Finland
- Registry status
- Completed
Technical summary
Registry record NCT01938261. Randomized; quadruple masking; primary purpose prevention. Start 2013-08 (actual); primary completion 2024-07-15 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Preterm Infants' Paracetamol Study
- Acronym
- PreParaS
- Condition
- Persistent Ductus Arteriosus
- Condition
- Complication of Prematurity
- Condition
- Pain or Discomfort in Intensive Care of Preterm Infants
- Intervention (Drug)
- paracetamol
- Intervention (Drug)
- 0.45 % saline solution
- Lead sponsor
- University of Oulu
Record details
- Record id
cardio:ct-nct01938261- Content hash
5fcd7ae098ea2b135790389a39ff6179a3af10bf752688e65a1b8c00f03d2c6c